ADIPOQ and obesity due to melanocortin 4 receptor deficiency: This large case-control study further supports the hypothesis that the T2D risk contribution of ENPP1, ADIPOQ, PPARG and TCF7L2 SNPs may be modulated by obesity status [6-8,11].